Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Adolesc Med ; 12(1): 95-104, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11224025

RESUMO

Chest pain invokes serious concern in adolescents, their families, and their primary care physicians. These concerns are fueled by media reports of sudden death in high-profile athletes and the high incidence of ischemic heart disease in our society. However, chest pain in this age group is usually benign and a careful clinical evaluation including a detailed history and physical examination may guide the clinician in reaching a diagnosis, obtaining the appropriate diagnostic studies, and making the proper referrals to specialists.


Assuntos
Dor no Peito/etiologia , Doenças Musculoesqueléticas/complicações , Adolescente , Arritmias Cardíacas/complicações , Dor no Peito/diagnóstico , Diagnóstico Diferencial , Cardiopatias Congênitas/complicações , Humanos , Atenção Primária à Saúde/métodos
2.
Am J Med Genet ; 75(1): 88-94, 1998 Jan 06.
Artigo em Inglês | MEDLINE | ID: mdl-9450864

RESUMO

We observed a girl with an interrupted, left inferior vena cava with hemiazygous continuation, bilateral superior venae cavae, heart defects, and sacral agenesis. She had macrostomia and bilateral ear tags and pits, as in oculoauriculovertebral defect. Maternal diabetes was present. The combination, which we call OAV-heterotaxia complex, supports the view that some cases of oculoauriculovertebral defect may be part of a midline field defect of blastogenesis.


Assuntos
Síndrome de Goldenhar/patologia , Veia Cava Inferior/anormalidades , Veia Cava Superior/anormalidades , Feminino , Síndrome de Goldenhar/diagnóstico por imagem , Síndrome de Goldenhar/genética , Cardiopatias Congênitas/diagnóstico por imagem , Cardiopatias Congênitas/genética , Cardiopatias Congênitas/patologia , Humanos , Recém-Nascido , Gravidez , Radiografia , Veia Cava Inferior/diagnóstico por imagem , Veia Cava Superior/diagnóstico por imagem
3.
Disabil Rehabil ; 18(8): 402-7, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8842625

RESUMO

While accessibility has increasingly become a concern in today's society, the implementation of this concern has failed to address many issues. This paper discusses the components of exclusivity, safety, and reasonability in accessibility. Common problems in the implementation of these factors are addressed. These elements in both design for accessibility and evaluation of accessibility, constitute the principle of accommodation in accessibility. The application of ergonomic principles to improve the accommodation of accessibility is proposed.


Assuntos
Acessibilidade Arquitetônica , Pessoas com Deficiência , Ergonomia , Antropometria , Humanos , Tecnologia Assistiva , Cadeiras de Rodas
5.
Arthritis Rheum ; 29(4): 501-7, 1986 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3486663

RESUMO

A sensitive in vitro bioassay for the alpha-interferon induction of lupus-type inclusions (LI) has been established with the human B lymphoblastoid cell line, Daudi. Sera from 11 patients with systemic lupus erythematosus (SLE) were evaluated with this assay. LI induction by these sera increased in proportion to their antiviral activity on Madin-Darby bovine kidney (MDBK) cells. Two of these sera did not induce LI; they showed no antiviral activity on the MDBK cell assay. Clinically and serologically, their donors were in remission. Two sera induced the formation of LI that exceeded the maximum frequencies obtained with 3 alpha-interferon preparations. These sera had the greatest antiviral activities, and their donors had the greatest disease activities. Antisera to alpha-interferons prevented the induction of LI with the pure and homogeneous recombinant human leukocyte interferon, IFLrA, and SLE sera. Together, these results provide evidence that the alpha-interferon endogenous to SLE patients has a great ability to induce LI, and the SLE serum induction of LI corresponds well to the patient's disease activity.


Assuntos
Corpos de Inclusão Viral/metabolismo , Lúpus Eritematoso Sistêmico/sangue , Animais , Antivirais/farmacologia , Antivirais/fisiologia , Linfócitos B , Linfoma de Burkitt/patologia , Bovinos , Linhagem Celular , Humanos , Interferon Tipo I/farmacologia , Rim , Lúpus Eritematoso Sistêmico/patologia
6.
Healthc Financ Manage ; 38(10): 60-6, 1984 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10315615

RESUMO

Under PPS an effective utilization management system is essential and the implementation of such systems presents a new challenge for hospital managers. An effective utilization management system must have the following characteristics: a process for establishing expected resource levels for each DRG; the ability to assign a working DRG at admission; a review schedule for each DRG; a method of identifying consistent patterns of high utilization; a focused review plan which targets selected DRG and physicians; a method of predicting the clinical treatment requirements of each patient; a review process which evaluates the need for continued hospitalization and identifies the reasons for any misutilization, and a feedback process which modifies the focused review plan on an ongoing basis. By operating a utilization management system with these attributes on a concurrent basis, a hospital will achieve the monitoring and control over its resources so critical under PPS. Hospitals that are able to successfully implement a utilization management system will have accomplished one of the essential components necessary to respond to PPS.


Assuntos
Mau Uso de Serviços de Saúde , Serviços de Saúde , Hospitais/estatística & dados numéricos , Sistema de Pagamento Prospectivo/economia , Mecanismo de Reembolso/economia , Revisão da Utilização de Recursos de Saúde , Serviços Técnicos Hospitalares/estatística & dados numéricos , Grupos Diagnósticos Relacionados , Eficiência , Humanos , Tempo de Internação/economia , Estados Unidos
8.
J Interferon Res ; 4(3): 335-45, 1984.
Artigo em Inglês | MEDLINE | ID: mdl-6092490

RESUMO

Raji and Daudi are human B lymphoblastoid cell lines that readily form lupus inclusions (LIs; TRS) when grown in medium supplemented with leukocyte-, or fibroblast-derived interferon (IFN-alpha, -beta, respectively). WISH, MDBK, and GM2504 are three cell lines commonly used to measure antiviral activities. None of them form LIs in their antiviral response to alpha or immune (gamma)IFN. This distinguishes between the abilities of a cell to develop an antiviral state and to form LIs in response to IFN. Human (Hu) lymphoblastoid IFN and the two pure and homogeneous recombinant human IFN-alpha proteins IFLrA and IFLrD induce LIs in Raji cells and Daudi cells. In Daudi, a simultaneous inhibition of cell growth occurs. When compared by antiviral activities, IFLrA inhibits the growth of Daudi cells more, while IFLrD induces the greater frequency of LIs. According to molecular concentration, IFLrA and IFLrD at 133 X 10(-13) M induce LIs in Daudi cells to their maximum frequency. Growth inhibition for these same cell samples is also at maximum for IFLrA, but only 25% of maximum for IFLrD. Our results with Raji and Daudi cells provide evidence against a cause-and-effect relationship between these two biologic responses to IFN by Daudi cells. They also provide evidence for distinct, but interacting, intracellular pathways. This phenomenon is a new explanation for some of the biologic diversity shown for the HuIFNs-alpha.


Assuntos
Linfócitos B/efeitos dos fármacos , Corpos de Inclusão/efeitos dos fármacos , Interferon Tipo I/farmacologia , Lúpus Eritematoso Sistêmico/patologia , Linfócitos B/imunologia , Linfócitos B/ultraestrutura , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Humanos , Interferência Viral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA